Gyros

About:

Gyros is specialized in the production of automated micro-immunoassays for therapeutic protein development.

Website: http://www.gyros.com

Twitter/X: gyrosassays

Top Investors: 3i Group, Industrifonden, HealthCap, Investor AB, Karolinska

Description:

Gyros is the world leader in automated micro-immunoassays for therapeutic protein development. Gyrolab, the company's automated and open platform, is a versatile analytical tool that dramatically reduces the time required to optimize and execute immunoassays. Time for assay optimization is often cut from weeks, to a matter of days. This results in increased efficiency in process development and in clinical evaluation of therapeutic proteins. The ease of assay transfer is unsurpassed in the industry.

Total Funding Amount:

$39.9M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Monmouth Junction, New Jersey, United States

Founded Date:

2000-01-01

Contact Email:

information(AT)gyros.com

Founders:

Maris Hartmanis

Number of Employees:

51-100

Last Funding Date:

2009-07-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai